Dr. Michael Cooper

Alcon announces FDA approval of the O-T-C switch of Pataday Once Daily Relief Extra Strength

Alcon announces FDA approval of the O-T-C switch of Pataday Once Daily Relief Extra Strength

GENEVA – Alcon announced Tuesday that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%), formerly prescribed as Pazeo, has been approved by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C) in the United States. Pataday Once Daily Relief Extra Strength is the first and only once daily eye allergy itch

How to address itchy eyes at the pharmacy counter or drive-thru window

How to address itchy eyes at the pharmacy counter or drive-thru window

Nearly 66 million (one in five) Americans suffer from itchy eyes caused by seasonal and/or perennial allergies. In any given year, pharmacists and health care professionals face questions during allergy season about itchy eye symptoms that can easily be confused with dry eye disease or viral infections. This year, many are now asking a new